2,2-Difluoro-2-(quinolin-8-yl)acetic acid
95%
- Product Code: 40526
CAS:
1501871-90-4
| Molecular Weight: | 223.18 g./mol | Molecular Formula: | C₁₁H₇F₂NO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
Primarily utilized in the pharmaceutical industry, this compound serves as a key intermediate in the synthesis of various biologically active molecules. Its unique structure, featuring a quinoline ring and difluoroacetic acid moiety, makes it valuable in the development of drugs targeting specific enzymes or receptors. It is particularly relevant in the creation of inhibitors for enzymes involved in inflammatory and neurodegenerative diseases. Additionally, its fluorinated structure enhances metabolic stability, making it a preferred choice in the design of compounds with improved pharmacokinetic properties. Researchers also explore its potential in the development of fluorescent probes for biological imaging, leveraging the quinoline group's inherent luminescent properties.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £120.50 |
+
-
|
| 0.250 | 10-20 days | £201.11 |
+
-
|
| 1.000 | 10-20 days | £526.80 |
+
-
|
2,2-Difluoro-2-(quinolin-8-yl)acetic acid
Primarily utilized in the pharmaceutical industry, this compound serves as a key intermediate in the synthesis of various biologically active molecules. Its unique structure, featuring a quinoline ring and difluoroacetic acid moiety, makes it valuable in the development of drugs targeting specific enzymes or receptors. It is particularly relevant in the creation of inhibitors for enzymes involved in inflammatory and neurodegenerative diseases. Additionally, its fluorinated structure enhances metabolic stability, making it a preferred choice in the design of compounds with improved pharmacokinetic properties. Researchers also explore its potential in the development of fluorescent probes for biological imaging, leveraging the quinoline group's inherent luminescent properties.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :